Zobrazeno 1 - 10
of 272
pro vyhledávání: '"G, Malara"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chiara Franchi, Giuseppe Argenziano, G. Malara, Rossana Tiberio, Stefano Piaserico, Maria Esposito, Marco Galluzzo, Gabriella Fabbrocini, Alessandra Narcisi, Andrea Chiricozzi, Maurizio Congedo, Elisa Cinotti, Giovanna Brunasso, Aurora Parodi
Publikováno v:
Expert Opinion on Biological Therapy. 22:367-376
Introduction: Tildrakizumab is a monoclonal antibody that targets the p19 subunit of IL-23, a crucial cytokine for Th17 cells. Tildrakizumab has been assessed in several Phase I, II, and III clinical trials and is approved for treatment of adults wit
Autor:
Tommaso Bianchelli, Ketty Peris, Nevena Skroza, R. Gallo, Viviana Piras, Caterina Foti, Maria Esposito, Franco Rongioletti, M C Fargnoli, Giuseppe Argenziano, Mark S. Talamonti, Silvia Ferrucci, Paolo D. Pigatto, N. Gori, L. Bolzano, A. Campitello, Paolo Amerio, Giulia Tonini, Annalisa Patrizi, Nicola Pimpinelli, S.P. Cannavò, Giuseppe Micali, Luca Bianchi, G. Malara, Monica Corazza, Ersilia Tolino, Anna Campanati, A. M. Offidani, Katharina Hansel, Aurora Parodi, Maria Concetta Potenza, Gabriella Fabbrocini, A. Borghi, Camilla Loi, F. Prigano, Luca Stingeni, Francesco Cusano, Marco Romanelli, Maria Letizia Musumeci, Paolo Romita, Giulia Calabrese, Simona Tavecchio, Giovanni Pellacani, L. Di Costanzo, Rosaria Gesuita
Publikováno v:
Archives of Dermatological Research. 314:593-603
Adult atopic dermatitis (adult AD) is a systemic inflammatory disorder, whose relationship with immune-allergic and metabolic comorbidities is not well established yet. Moreover, treatment of mild-to-moderate and severe atopic dermatitis needs standa
Publikováno v:
Drugs in Context, Vol 10, Pp 1-8 (2021)
Drugs in Context
Drugs in Context
Background Dimethyl fumarate (DMF) is an oral systemic agent approved for the treatment of moderate-to-severe psoriasis vulgaris. It has a favourable tolerability profile, but it is associated with a high incidence of mild and reversible adverse even
Autor:
Luca Stingeni, Andrea Chiricozzi, Piergiorgio Malagoli, Anna Campanati, Marina Venturini, Antonio Costanzo, Anna Balato, Paolo Gisondi, Clara De Simone, Giampiero Girolomoni, Maria Letizia Musumeci, Aurora Parodi, Franco Rongioletti, Angelo Cattaneo, Claudia Lasagni, Santo Raffaele Mercuri, Valentina Dini, Francesca Prignano, Federico Bardazzi, Concetta Potenza, Claudio Guarneri, Ada Lo Schiavo, Ketty Peris, A. M. Offidani, Manuela Papini, Paolo Dapavo, Francesco Loconsole, Maria Laura Flori, Francesco Cusano, Maria Concetta Fargnoli, Stefano Piaserico, Marco Galluzzo, Paolo Amerio, Piergiacomo Calzavara Pinton, Luca Bianchi, Marina Talamonti, Luigi Naldi, Rossana Tiberio, G. Malara
Publikováno v:
Dermatology and Therapy
Introduction: Treat-to-target strategies are used in several chronic diseases to improve outcomes. Treatment goals have also been suggested for psoriasis, but there is currently no consensus on targets, and guidance is needed to implement this strate
Autor:
Graziella D'Arrigo, Cristina Politi, Chiara Verduci, Giovanni Tripepi, Alessandra Testa, G. Malara, Caterina Trifirò
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 9, p adv00545 (2021)
Apremilast is an oral selective phosphodiesterase-4 inhibitor developed recently for psoriasis treatment. The aim of this study is to assess the real-life outcomes of use of apremilast in patients with psoriasis in everyday clinical practice. A total
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 12, Pp 2944-2946 (2020)
Clinical Case Reports, Vol 8, Iss 12, Pp 2944-2946 (2020)
Atopic dermatitis is associated with a susceptibility to infection usually by Staphylococcus spp due to a decrease of AMPs and Th2 cytokines (eg, IL‐17). We reported a rare E. faecalis skin contamination in AD patients due to a frequent contact wit
Autor:
G, Malara, C, Trifirò, A, Bartolotta, C, Giofré, G, D'Arrigo, A, Testa, A, De Lorenzo, G, Tripepi
Publikováno v:
European review for medical and pharmacological sciences. 25(1)
Guselkumab is a fully human monoclonal IgG1 antibody which, by selectively binding to the p19 subunit of IL-23, prevents it from binding to the IL-23 receptor on the cell surfaces. To date, no prospective data are available on the efficacy and safety
Autor:
Rossana Tiberio, Maria Grazia Aragone, Antonio Costanzo, Serena Lembo, Claudia Leporati, Giuseppe Argenziano, Paola Savoia, Antonio Giovanni Richetta, G. Malara, Rocco De Pasquale, Claudia Giofrè, Maria Concetta Fargnoli, Gianpiero Castelli, Luca Bianchi, Manuela Baldari, Maria Teresa Uzzauto, Paolo Amerio, Ginevra Baggini, Simmaco Coppola, Massimo Travaglini, Ketty Peris, Francesco Loconsole, Caterina Foti
Publikováno v:
Patient preference and adherence
Patient Preference and Adherence, Vol Volume 15, Pp 2551-2562 (2021)
Patient Preference and Adherence, Vol Volume 15, Pp 2551-2562 (2021)
Giuseppe Argenziano,1,* Paolo Amerio,2 Maria Grazia Aragone,3 Ginevra Baggini,4 Manuela Baldari,5 Gianpiero Castelli,6 Simmaco Coppola,7 Antonio Costanzo,8,9 Rocco De Pasquale,10 Maria Concetta Fargnoli,11 Caterina Foti,12 Claudia Giofrè,13 Serena L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef85fafe60f27d9f6140f4f44d389869
http://hdl.handle.net/2108/304601
http://hdl.handle.net/2108/304601